Gynecomastia in patients with prostate cancer: update on treatment options

被引：17

作者：

Autorino, R.

Perdona, S.

D'Armiento, M.

De Sio, M.

Damiano, R.

Cosentino, L.

Di Lorenzo, G.

机构：

[1] Seconda Univ Studi, Urol Clin, I-80132 Naples, Italy

[2] Fdn G Pascale IRCSS, INT, UO Urol, Naples, Italy

[3] Univ Magna Graecia, Cattedra Urol, Catanzaro, Italy

[4] Univ Naples Federico II, Cattedra Oncol Med, Naples, Italy

来源：

PROSTATE CANCER AND PROSTATIC DISEASES | 2006年 / 9卷 / 02期

关键词：

gynecomastia; hormonal treatment; bicalutamide; prostate cancer; radiotherapy; tamoxifen;

D O I：

10.1038/sj.pcan.4500859

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Non-steroidal antiandrogen monotherapy offers potential quality of life benefits over other treatment modalities in patients with prostate cancer. Nevertheless, gynecomastia and breast pain still represent the most bothersome side effects during this treatment. In this update article, recent advances in the management options for gynecomastia/breast pain caused by hormonal manipulation are reviewed and critically analyzed.

引用

收藏

页码：109 / 114

页数：6

相关论文

共 32 条

[1] Combination of low-dose flutamide and finasteride for psa-only recurrent prostate cancer after primary therapy [J].

Barqawi, AB ;

Moul, JW ;

Ziada, A ;

Handel, L ;

Crawford, ED .

UROLOGY, 2003, 62 (05) :872-876

[2] Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer [J].

Boccardo, F ;

Rubagotti, A ;

Battaglia, M ;

Di Tonno, P ;

Selvaggi, FP ;

Conti, G ;

Comeri, G ;

Bertaccini, A ;

Martorana, G ;

Galassi, P ;

Zattoni, F ;

Macchiarella, A ;

Siragusa, A ;

Muscas, G ;

Durand, F ;

Potenzoni, D ;

Manganelli, A ;

Ferraris, V ;

Montefiore, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :808-815

[3] Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: Updated results of a multicentric trial [J].

Boccardo, F ;

Barichello, M ;

Battaglia, M ;

Carmignani, G ;

Comeri, G ;

Ferraris, V ;

Lilliu, S ;

Montefiore, F ;

Portoghese, F ;

Cortellini, P ;

Rigatti, P ;

Usai, E ;

Rubagotti, A .

EUROPEAN UROLOGY, 2002, 42 (05) :481-489

[4] Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma [J].

Studer, UE .

EUROPEAN UROLOGY, 1997, 32 (04) :395-396

[5] Aromatase and gynecomastia [J].

Braunstein, GD .

ENDOCRINE-RELATED CANCER, 1999, 6 (02) :315-324

[6] Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: Flutamide versus diethylstilbestrol [J].

Chang, A ;

Yeap, B ;

Davis, T ;

Blum, R ;

Hahn, R ;

Khanna, O ;

Fisher, H ;

Rosenthal, J ;

Witte, R ;

Schinella, R ;

Trump, D .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2250-2257

[7] A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA [J].

CRAWFORD, ED ;

EISENBERGER, MA ;

MCLEOD, DG ;

SPAULDING, JT ;

BENSON, R ;

DORR, FA ;

BLUMENSTEIN, BA ;

DAVIS, MA ;

GOODMAN, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) :419-424

[8] MONOTHERAPY WITH NILUTAMIDE, A PURE NONSTEROIDAL ANTIANDROGEN, IN UNTREATED PATIENTS WITH METASTATIC CARCINOMA OF THE PROSTATE [J].

DECENSI, AU ;

BOCCARDO, F ;

GUARNERI, D ;

POSITANO, N ;

PAOLETTI, MC ;

COSTANTINI, M ;

MARTORANA, G ;

GIULIANI, L .

JOURNAL OF UROLOGY, 1991, 146 (02) :377-381

[9] Maximal androgen blockade: Final analysis of EORTC phase III trial 30853 [J].

Denis, LJ ;

Keuppens, F ;

Smith, PH ;

Whelan, P ;

de Moura, JLC ;

Newling, D ;

Bono, A ;

Sylvester, R .

EUROPEAN UROLOGY, 1998, 33 (02) :144-151

[10] Once weekly tamoxifen in the prevention of gynaaecomastia and breast pain secondary to bicalutamide therapy [J].

Eaton, AC ;

Makris, A ;

Makris, A .

JOURNAL OF UROLOGY, 2004, 171 (04) :282-282

← 1 2 3 4 →